Unknown

Dataset Information

A randomized, placebo-controlled trial to determine the course of aminotransferase elevation during prolonged acetaminophen administration.


ABSTRACT:

Background

Acetaminophen administration for more than 4 days causes aminotransferase elevation in some subjects. The objective of this randomized, placebo-controlled trial is to describe the course of alanine aminotransferase (ALT) elevation in subjects administered 4 g/day of acetaminophen for at least 16 days.

Methods

A randomized, placebo controlled trial of acetaminophen (4 g/day) vs placebo. Subjects were healthy volunteers with normal liver enzymes. The primary outcome was the course of ALT during acetaminophen administration. All subjects were treated for a minimum of 16 days. Subjects with ALT elevation at day 16 were continued on treatment until these elevations resolved up to a maximum of 40 days. Subjects were also evaluated for elevation of INR or serum bilirubin

SUBMITTER: Heard K 

PROVIDER: S-EPMC4118644 | biostudies-literature | 2014 Jul

REPOSITORIES: biostudies-literature